Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Scott

Showing results (31-40 of 355) with videos related to

Pageof 36
Sort By:
British Journal of Haematology|November 8, 2011
Gene therapy for haemophilia: prospects and challenges to prevent or reverse inhibitor formationDavid W Scott, Jay N Lozier
Blood|March 17, 2005
Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteinsTie Chi Lei, David W Scott
Nature Reviews. Cancer|July 11, 2014
The tumour microenvironment in B cell lymphomasDavid W Scott, Randy D Gascoyne
Best Practice & Research. Clinical Haematology|September 15, 2018
Dissecting aggressive B-cell lymphoma through genomic analysis - What is clinically relevant?David W Scott, Lisa M Rimsza
Frontiers in Immunology|February 4, 2020
Factor VIII: Perspectives on Immunogenicity and Tolerogenic StrategiesDavid W Scott, Kathleen P Pratt
Cellular Immunology|December 11, 2020
Novel T regulatory cells come of age: The curious incident of a mouse in Tennessee, delayed thymectomy and chimeric receptors!David W Scott, Megan K Levings
Cancer Discovery|April 1, 2022
Harnessing Mitochondrial Mutations to ATAC Clonal Evolution in CLLLaura K Hilton, David W Scott
Cellular Immunology|July 25, 2006
Treatment of diabetes in NOD mice by gene transfer of Ig-fusion proteins into B cells: role of T regulatory cellsNadejda Soukhareva, Yufei Jiang, David W Scott
Trends in Immunology|October 30, 2007
Immunogenicity of protein therapeuticsAnne S De Groot, David W Scott
Discovery Medicine|June 4, 2013
Tolerance induction in hemophilia A animal models: battling inhibitors with antigen-specific immunotherapiesPatrick Adair, Yan Su, David W Scott
Pageof 36

Showing results (31-40 of 355) with videos related to

Sort By:
Pageof 36
British Journal of Haematology|November 8, 2011
Gene therapy for haemophilia: prospects and challenges to prevent or reverse inhibitor formationDavid W Scott, Jay N Lozier
Blood|March 17, 2005
Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteinsTie Chi Lei, David W Scott
Nature Reviews. Cancer|July 11, 2014
The tumour microenvironment in B cell lymphomasDavid W Scott, Randy D Gascoyne
Best Practice & Research. Clinical Haematology|September 15, 2018
Dissecting aggressive B-cell lymphoma through genomic analysis - What is clinically relevant?David W Scott, Lisa M Rimsza
Frontiers in Immunology|February 4, 2020
Factor VIII: Perspectives on Immunogenicity and Tolerogenic StrategiesDavid W Scott, Kathleen P Pratt
Cellular Immunology|December 11, 2020
Novel T regulatory cells come of age: The curious incident of a mouse in Tennessee, delayed thymectomy and chimeric receptors!David W Scott, Megan K Levings
Cancer Discovery|April 1, 2022
Harnessing Mitochondrial Mutations to ATAC Clonal Evolution in CLLLaura K Hilton, David W Scott
Cellular Immunology|July 25, 2006
Treatment of diabetes in NOD mice by gene transfer of Ig-fusion proteins into B cells: role of T regulatory cellsNadejda Soukhareva, Yufei Jiang, David W Scott
Trends in Immunology|October 30, 2007
Immunogenicity of protein therapeuticsAnne S De Groot, David W Scott
Discovery Medicine|June 4, 2013
Tolerance induction in hemophilia A animal models: battling inhibitors with antigen-specific immunotherapiesPatrick Adair, Yan Su, David W Scott
Pageof 36